STAT SOLITAIRE™ THROMBECTOMY + ASPIRATION THERAPY
A comprehensive solution that works together in the fight against acute ischemic stroke.
DOWNLOAD BROCHUREA SYSTEM DESIGNED
FOR COMPATIBILITY1
When you use a comprehensive, compatible1 solution, you’re set for success to make quick decisions in the fight against acute ischemic stroke.
When time is brain, there’s no need to think twice about your procedural decisions when you need to act fast. With Solitaire Thrombectomy + Aspiration Therapy (STAT), you’ve got greater freedom and flexibility using our comprehensive, compatible portfolio of Solitaire, React™ and Riptide™.
Partner with Medtronic and focus on what matters — the urgent care you need to provide — to give patients a better chance to walk away from an acute ischemic stroke (AIS).
COMBINATION THERAPY
AN APPROACH BACKED BY DATA6
A combined approach by SR + CA proved to be associated with a better percentage of FPE (First Pass Effect).6
The ability to combine these powerful technologies — Solitaire, Phenom™, React and Riptide — means you can have true peace of mind knowing you can use these solutions together, on-label, if and when you need them.
STAT
IS COMPREHENSIVE.
STAT is comprised of:
- Solitaire X Revascularization Device
Clinically proven stent retriever with unique parametric design for dynamic clot integration and retrieval2*,3 - React Catheter
Designed with an end-to-end nitinol overlapping combination of coil and braid that provides navigability, pushability, and durability1,4 - Riptide Aspiration System
Aspiration source for the Solitaire X device
* Clinical studies include Solitaire Platinum Revascularization Device and Solitaire Revascularization Device. React and Riptide were not included.
STAT
IS COMPATIBLE.
SOLITAIRE + REACT:
- React Catheter
was purposefully designed to be compatible with the Solitaire X Revascularization Device1 - Solitaire X Device
can be delivered through the React Catheter and withdrawn back into the catheter to retrieve the thrombus under aspiration without causing damage to the catheter
SOLITAIRE+PHENOM:
- The combination of the Phenom 21 Catheter and the Solitaire X Device provides smooth deliverability with a low clot crossing profile.
STAT
IS CONVENIENT.
With STAT, you are set up to make quick decisions in the fight against AIS.
- One committed partner for AIS
- Solitaire X-PACK, essential kit. A comprehensive compatible stroke solution available in a single package.
- STAT Stroke Cart to store all Medtronic products needed for AIS procedure in one convenient place
INNOVATING FASTER TO ADVANCE OUTCOMES —
WITH STAT, WE CAN TAKE AIS TREATMENT FURTHER, TOGETHER.
DESIGNED FOR COMPATIBILITY.1
CREATED FOR CONVENIENCE.
SOLITAIRE X
REVASCULARIZATION DEVICE
The Solitaire X revascularization device, featuring Parametric™ design, a unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO).
The Solitaire device is indicated to reduce stroke-related disability by showing nearly 70% relative improvement in functional outcomes at 90 days in patients suffering LVO.5
REACT CATHETER
The React Catheter features a coil and braid design along with end-to-end Nitinol construction—easing navigation to the M1 and M2 segments. This catheter combined with the Solitaire device and the Riptide Aspiration System is designed to revascularize patients experiencing acute ischemic stroke.
Indications, Safety, and Warnings — React Catheter
Indications, Safety, and Warnings — Riptide Aspiration System
RIPTIDE
ASPIRATION SYSTEM
The Riptide Aspiration System is an aspiration thrombectomy system designed to retrieve a blood clot and restore blood flow to occluded vessels in the brain for patients experiencing acute ischemic stroke due to a large vessel occlusion.
1
TR-NV16168A
2
ESCAPE, SWIFT PRIME, Nasa Registry, STRATIS, THRACE, MR CLEAN, STAR, EXTEND IA, HERMES, SEER, REVASCAT
3
TR-NV13807 Rev A
4
DWGS50969 Rev 7
5
71011-001 Rev 06/17
6
Di Maria et al. Identifying the predictors of first-pass effect and its influence on clinical outcome in the setting of endovascular thrombectomy for acute ischemic stroke: Results from a multicentric prospective registry. International Journal of Stroke. (0) 0 2020.
CAUTION: Federal (USA) law restricts these devices to sale distribution and use by or on order of a physician. Indications, contraindications, warnings and instructions for use for Solitaire™ X Revascularization Device can be viewed at www.medtronic.com/manuals. Indications, contraindications, warnings and instructions for all other products can be found in the product labeling supplied with each device.
The React™ 68 Catheter and React™ 71 Catheter are indicated for the introduction of interventional devices into the peripheral and neuro vasculature.
The Riptide™ Aspiration System is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Phenom™ Catheters are intended for the introduction of interventional devices and infusion of diagnostic or therapeutic agents into the neuro, peripheral, and coronary vasculatures.